www.cawachi.co.jp/wp/wp-content/uploads/ir-tan20251029.pdf

Latest saved version

2026年３月期 第２四半期決算短信〔日本基準〕（連結）

This is the newest public snapshot for this URL and the best place to start reviewing the page.

Source URL

https://www.cawachi.co.jp/wp/wp-content/uploads/ir-tan20251029.pdf

About this page

This document is the financial results report for the second quarter (interim period) of the fiscal year ending March 2026 for Kawachi Pharmaceutical Co., Ltd., published on October 29, 2025. The report indicates that sales amounted to 145.357 billion yen, a 1.4% decrease compared to the same period last year. Operating profit decreased by 21.9% to 3.209 billion yen, while ordinary profit fell by 16.2% to 3.806 billion yen. Net profit attributable to shareholders was 2.457 billion yen, down 9.5%. Despite a gradual economic recovery, the company faces intensified competition and rising prices. Kawachi Pharmaceutical has expanded its product offerings in health foods and adjusted prices, operating a total of 385 stores.